Why is iPlus useful?
iPlus has particular benefit in the production of marketing documents and statutory reporting within a highly regulated environment, such as the Pharmaceutical and Financial Services industries. The iPlus approach has been particularly successful with clients such as Theadneedle Asset Management and Mellon Global Investments (MGI), in dramatically lowering costs, increasing productivity and increasing the variety and depth of reporting. In the case of MGI, this has equated to the very dramatic cost saving of 75% per annum in their document creation costs, causing a Return On Investment (ROI) within 3 months, and a ten fold increase in the variety of their reporting. These figures are taken from the MGI case study. A further case study developed by both MGI and Adobe can be seen here on Adobe’s US website.
